Simulations Plus Inc
Research Simulations Plus Inc (SLP) on Bullrun: market cap USD 371.38M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSLP
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyUSD
- Market capUSD 371.38M
- Financial periodFY2025
- RevenueUSD 79.18M
- Revenue growth13.1%
- Net income-USD 64.72M
- Free cash flowUSD 17.41M
- Gross margin58.4%
Valuation Snapshot
latest market cap is USD 371.38M.
About Simulations Plus Inc
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products.
Frequently asked questions
What is Simulations Plus Inc's market cap?
Simulations Plus Inc's market capitalization is USD 371.38M.
What does Simulations Plus Inc do?
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments.